In addition, no significant differences were found in the antibody levels at different time points in patients with and without a history of pneumocystosis or in patients with CD4+ cell counts <50 cells/μL or patients with CD4+ counts >50 cells/μL (data not shown). This evidence concerns the gene CD4 and pneumocystosis.